AS · est 2014OsloParent · 3 subsidiaries
Brreg · companies
headcount series appears after two register changes
Roles from Brreg, shown for business contact only. No birth date is shown or exported (purpose limitation, GDPR Art. 6(1)(f)).
Brreg · company_people
2 registered roles
| Daglig leder | Roy Hartvig Larsen Multiple boards | 2014-03-11 | |
| Styrets leder | Roy Hartvig Larsen Multiple boards | 2014-03-11 |
NOK, amounts in thousands
| 2024 | 2025 | ||
|---|---|---|---|
| Revenue | 4 627 | ||
| Operating result | 3 430 | ||
| Result before tax | −3 159 | ||
| Net result | −3 530 | ||
| Total assets | 43 417 | ||
| Equity | 42 876 |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | 4 627 | ||||||
| Operating result | 3 430 | ||||||
| Result before tax | −3 159 | ||||||
| Net result | −3 530 | ||||||
| Total assets | 43 417 | ||||||
| Equity | 42 876 |
Regnskapsregisteret · company_revenue · FY2025 (company)
No corporate shareholders recorded.
Aksjonærregisteret · company_ownership · both directions
| 2024 | 2025 | 2026 | |
|---|---|---|---|
| auditor REVISORKOLLEGIET AS 2026-06-23 | ● | ||
| accountant — |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|
| auditor REVISORKOLLEGIET AS 2026-06-23 | ● | ||||||
| accountant — |
Brreg · company_org_roles
No recorded tender wins.
Relevant open tenders — matched · NACE 72.100 ↔ CPVsubscribers sharpen matches with per-company keywords
open-tender matching (NACE ↔ CPV) awaits Intelligo's open-tenders view
Doffin/TED · company_tender_wins · 2026-08-14
No job ads on record in the last 12 months.
NAV Arbeidsplassen · company_job_ad_months
Group revenue kr 83.8MGroup net kr 2.53MTenders won 0Rolled up across the parent + 3 subsidiaries — Artbio AS alone is kr 74.3M.
rollup estimate · filed konsernregnskap not yet in Intelligo
| Nuclithera AS | 75.5% | Research and experimental development on natural sciences and engineering | kr 4.86M |
| SRB Radiopharma Holding AS | 59.1% | Research and experimental development on natural sciences and engineering | |
| Artbio AS | 53.4% | Research and experimental development on natural sciences and engineering | kr 74.3M |
| 5.3% | |||
| 3.4% | |||
| Oncoinvent ASA | 1.4% | ||
| Thor Medical ASA | 0.6% | ||
| Extraction Technologies Norway AS | 0.3% | ||
| Voim ASA | 0.0% | ||
| Sparebanken Øst | 0.0% | ||
| Norsk Titanium AS | 0.0% | ||
| Veidekke ASA | 0.0% | ||
| 0.0% | |||
| Sparebanken Norge | 0.0% | ||
| Elkem ASA | 0.0% |
+18 more holdings
Aksjonærregisteret · company_ownership · both directions
This company's annual report has not been read yet. The filed figures above come from the accounts form; everything the board wrote around them is in the PDF, which is read on request.
Regnskapsregisteret (årsberetning) · company_annual_reports
registered 2014-03-1192016487
Brreg · companies
register ledger · no events
No dated events on file
Skiwo · company_events